Search research articles
Contact Us
Filters
Showing results (61-70 of 88) with videos related to
Page
of 9
Sort By:
Cancers
|
June 2, 2021
Synthesis and Characterization of Radiogallium-Labeled Cationic Amphiphilic Peptides as Tumor Imaging Agents
Takeshi Fuchigami, Takeshi Chiga, Sakura Yoshida, et al.
RSC Medicinal Chemistry
|
December 23, 2022
Synthesis and evaluation of radiolabeled porphyrin derivatives for cancer diagnoses and their nonradioactive counterparts for photodynamic therapy
Nur Izni Ramzi, Kenji Mishiro, Masayuki Munekane, et al.
Chemical & Pharmaceutical Bulletin
|
March 1, 2022
Synthesis and Characterization of Hydroxyethylamino- and Pyridyl-Substituted 2-Vinyl Chromone Derivatives for Detection of Cerebral Abnormal Prion Protein Deposits
Mari Nakaie, Fumihiro Katayama, Takehiro Nakagaki, et al.
Biological & Pharmaceutical Bulletin
|
November 6, 2003
Synthesis and brain regional distribution of [11C]NPS 1506 in mice and rat: an N-methyl-D-aspartate (NMDA) receptor antagonist
Takeshi Fuchigami, Terushi Haradahira, Takuya Arai, et al.
Bioorganic & Medicinal Chemistry
|
January 3, 2017
Development of radioiodinated acridine derivatives for in vivo imaging of prion deposits in the brain
Masao Kawasaki, Takeshi Fuchigami, Nobuya Kobashi, et al.
Molecules (Basel, Switzerland)
|
July 12, 2025
Engineering a Radiohybrid PSMA Ligand with an Albumin-Binding Moiety and Pharmacokinetic Modulation via an Albumin-Binding Competitor for Radiotheranostics
Saki Hirata, Hiroaki Echigo, Masayuki Munekane, et al.
Molecular Pharmaceutics
|
October 24, 2024
Development of Radiolabeled Probes with Improved Imaging Contrast by Releasing Urinary Excretable Radiolabeled Compounds from Thermosensitive Liposomes in the Blood
Masayuki Munekane, Miki Ozaki, Yuri Mitani, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 11, 2023
Development of probes for radiotheranostics with albumin binding moiety to increase the therapeutic effects of astatine-211 (<sup>211</sup>At)
Hiroaki Echigo, Kenji Mishiro, Masayuki Munekane, et al.
Nuclear Medicine and Biology
|
October 15, 2025
Evaluation of an <sup>211</sup>At-labeled RGD peptide in an orthotopic glioblastoma model by targeted alpha therapy
Hiroaki Echigo, Masayuki Munekane, Takeshi Fuchigami, et al.
Chemical & Biomedical Imaging
|
October 30, 2024
Peptide-Based Turn-On Fluorescent Probes for Highly Specific Detection of Survivin Protein in the Cancer Cells
Takeshi Fuchigami, Tomoe Nakayama, Yusuke Miyanari, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 88) with videos related to
Sort By:
Page
of 9
Cancers
|
June 2, 2021
Synthesis and Characterization of Radiogallium-Labeled Cationic Amphiphilic Peptides as Tumor Imaging Agents
Takeshi Fuchigami, Takeshi Chiga, Sakura Yoshida, et al.
RSC Medicinal Chemistry
|
December 23, 2022
Synthesis and evaluation of radiolabeled porphyrin derivatives for cancer diagnoses and their nonradioactive counterparts for photodynamic therapy
Nur Izni Ramzi, Kenji Mishiro, Masayuki Munekane, et al.
Chemical & Pharmaceutical Bulletin
|
March 1, 2022
Synthesis and Characterization of Hydroxyethylamino- and Pyridyl-Substituted 2-Vinyl Chromone Derivatives for Detection of Cerebral Abnormal Prion Protein Deposits
Mari Nakaie, Fumihiro Katayama, Takehiro Nakagaki, et al.
Biological & Pharmaceutical Bulletin
|
November 6, 2003
Synthesis and brain regional distribution of [11C]NPS 1506 in mice and rat: an N-methyl-D-aspartate (NMDA) receptor antagonist
Takeshi Fuchigami, Terushi Haradahira, Takuya Arai, et al.
Bioorganic & Medicinal Chemistry
|
January 3, 2017
Development of radioiodinated acridine derivatives for in vivo imaging of prion deposits in the brain
Masao Kawasaki, Takeshi Fuchigami, Nobuya Kobashi, et al.
Molecules (Basel, Switzerland)
|
July 12, 2025
Engineering a Radiohybrid PSMA Ligand with an Albumin-Binding Moiety and Pharmacokinetic Modulation via an Albumin-Binding Competitor for Radiotheranostics
Saki Hirata, Hiroaki Echigo, Masayuki Munekane, et al.
Molecular Pharmaceutics
|
October 24, 2024
Development of Radiolabeled Probes with Improved Imaging Contrast by Releasing Urinary Excretable Radiolabeled Compounds from Thermosensitive Liposomes in the Blood
Masayuki Munekane, Miki Ozaki, Yuri Mitani, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 11, 2023
Development of probes for radiotheranostics with albumin binding moiety to increase the therapeutic effects of astatine-211 (<sup>211</sup>At)
Hiroaki Echigo, Kenji Mishiro, Masayuki Munekane, et al.
Nuclear Medicine and Biology
|
October 15, 2025
Evaluation of an <sup>211</sup>At-labeled RGD peptide in an orthotopic glioblastoma model by targeted alpha therapy
Hiroaki Echigo, Masayuki Munekane, Takeshi Fuchigami, et al.
Chemical & Biomedical Imaging
|
October 30, 2024
Peptide-Based Turn-On Fluorescent Probes for Highly Specific Detection of Survivin Protein in the Cancer Cells
Takeshi Fuchigami, Tomoe Nakayama, Yusuke Miyanari, et al.
Page
of 9